0000890465-13-000023.txt : 20130924
0000890465-13-000023.hdr.sgml : 20130924
20130924163010
ACCESSION NUMBER: 0000890465-13-000023
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130920
FILED AS OF DATE: 20130924
DATE AS OF CHANGE: 20130924
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NPS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000890465
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 870439579
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 550 HILLS DRIVE
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
BUSINESS PHONE: (908) 450-5300
MAIL ADDRESS:
STREET 1: 550 HILLS DRIVE
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BESHAR LUKE M
CENTRAL INDEX KEY: 0001192128
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23272
FILM NUMBER: 131112551
MAIL ADDRESS:
STREET 1: 550 HILLS DRIVE
STREET 2: 3RD FLOOR
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2013-09-20
0000890465
NPS PHARMACEUTICALS INC
NPSP
0001192128
BESHAR LUKE M
550 HILLS DRIVE
BEDMINSTER
NJ
07921
0
1
0
0
EVP & CFO
Common Stcok
2013-09-20
4
M
0
45000
5.71
A
104180
D
Common Stock
2013-09-20
4
M
0
5000
5.85
A
109180
D
Common Stock
2013-09-20
4
S
0
14000
30.429
D
95180
D
Common Stock
2013-09-20
4
S
0
19000
30.146
D
76180
D
Common Stock
2013-09-20
4
S
0
12000
30.32
D
64180
D
Common Stcok
2013-09-20
4
S
0
5000
30.051
D
59180
D
Stock Options
5.71
2013-09-20
4
M
0
45000
0
D
2019-01-20
Common Stock
45000
0
D
Stock Options
5.85
2013-09-20
4
M
0
5000
0
D
2018-10-15
Common Stock
5000
7310
D
The shares were sold pursuant to a predefined price target in a trading plan qualified under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended, that was effective August 16, 2013.
On January 20, 2009, the Reporting Person received a grant of 45,000 stock options under the Issuer's 1998 Stock Option Plan. The options become exercisable based on the following vesting schedule: 25% on the first anniversary of the grant and 6.25% every three months thereafter. As of the date of this filing, all 45,000 stock options have vested.
On October 15, 2008, the Reporting Person recevied a grant of 12,310 stock options under the Issuer's Stock 1998 Stock Option Plan. The options become exercisable based on the following vesting schedule: 28% on the first anniversary of the grant and 2% each month thereafter. As of the date of this filing, all 12,310 stock options have vested.
/s/ Luke Beshar, by Edward Stratemeier as attorney-in-fact
2013-09-24